{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T13:49:31Z","timestamp":1726408171114},"reference-count":35,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T00:00:00Z","timestamp":1405987200000},"content-version":"vor","delay-in-days":3642,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Dermatology"],"published-print":{"date-parts":[[2004,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We report a case treated with interferon beta\u20101b for multiple sclerosis (MS), who developed severe cutaneous ulcers after six months of therapy. Interferon beta\u20101b had been used in a regimen of 8 million IU administered subcutaneously through oblique direction of the needle, twice a week. The cutaneous ulcers developed at inoculation sites, as a result of penetration of interferon beta into dermis. Other underlying diseases of coagulative or bleeding disorders or secondary infection were excluded. Histological features of non\u2010specific inflammatory reactions including hyperplastic changes of blood vessels without any evidence of vasculitis were the prominent features in this case. Corticosteroid and interferon beta\u20101b therapy was continued on restricted sites on the extremities with care not to repeat injections at the same sites previously used. The administration of interferon beta into subcutaneous fatty tissues vertically reduced the incidence of dermal penetration of drug and occurrence of ulcerations in this patient. We review other case reports of severe cutaneous reactions associated with interferon beta\u20101b therapy in MS patients and conclude that local cytokine\u2010mediated, adverse, immune reaction or non\u2010specific cutaneous inflammatory reaction to interferon beta\u20101b initiated the skin ulceration long after institution of therapy at the injection sites, and the reaction might be related to the depth of injection.<\/jats:p>","DOI":"10.1111\/j.1346-8138.2004.tb00575.x","type":"journal-article","created":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T09:36:34Z","timestamp":1406021794000},"page":"671-677","source":"Crossref","is-referenced-by-count":13,"title":["Cutaneous Ulcerations Following Subcutaneous Interferon \u03b2 Injection to a Patient with Multiple Sclerosis"],"prefix":"10.1111","volume":"31","author":[{"given":"Hisashi","family":"Inafuku","sequence":"first","affiliation":[{"name":"Division of Dermatology, Organ\u2010oriented Medicine, School of Medicine, Faculty of Medicine University of the Ryukyus  Okinawa Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed Abul Kasem","family":"Khan","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Organ\u2010oriented Medicine, School of Medicine, Faculty of Medicine University of the Ryukyus  Okinawa Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Nagata","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Organ\u2010oriented Medicine, School of Medicine, Faculty of Medicine University of the Ryukyus  Okinawa Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Nonaka","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Organ\u2010oriented Medicine, School of Medicine, Faculty of Medicine University of the Ryukyus  Okinawa Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,7,22]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(89)90236-3"},{"key":"e_1_2_4_3_1","first-page":"608","article-title":"Biology of disease. Analysis of autoimmune demyelination: Its impact upon multiple sclerosis","volume":"50","author":"Raine C","year":"1984","journal-title":"Lab Invest"},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00792605"},{"key":"e_1_2_4_5_1","first-page":"229","article-title":"Immunology of multiple sclerosis","volume":"2","author":"Williams KC","year":"1994","journal-title":"Clin Neurosci"},{"key":"e_1_2_4_6_1","first-page":"246","article-title":"Is multiple sclerosis an autoimmune disease?","volume":"2","author":"Gulcher JR","year":"1994","journal-title":"Clin Neurosci"},{"key":"e_1_2_4_7_1","first-page":"1","article-title":"Multiple sclerosis: Experimental and clinical aspects","volume":"436","author":"Scheinberg L","year":"1984","journal-title":"Ann N Y Acad Sci"},{"key":"e_1_2_4_8_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.4.655"},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.7.1277"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410390304"},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.49.2.358"},{"key":"e_1_2_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)03334-0"},{"key":"e_1_2_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)10039-9"},{"key":"e_1_2_4_14_1","doi-asserted-by":"publisher","DOI":"10.1177\/135245859800400205"},{"key":"e_1_2_4_15_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.2.552"},{"key":"e_1_2_4_16_1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2340\/00015555577146148","article-title":"Cutaneous necrosis associated with recombinant interferon injection. Report of 3 cases with interferon \u03b2\u20101b and review of the literature","volume":"77","author":"Weinberg JM","year":"1997","journal-title":"Acta Derma Venereol"},{"key":"e_1_2_4_17_1","first-page":"65","article-title":"Management of side effects of beta\u2010interferon therapy in MS","volume":"5","author":"Walther EU","year":"1998","journal-title":"Int MSJ"},{"key":"e_1_2_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(07)80010-7"},{"key":"e_1_2_4_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199506083322316"},{"key":"e_1_2_4_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1998.tb05908.x"},{"key":"e_1_2_4_21_1","doi-asserted-by":"publisher","DOI":"10.1159\/000245687"},{"key":"e_1_2_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(94)90388-3"},{"key":"e_1_2_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)70170-1"},{"key":"e_1_2_4_24_1","doi-asserted-by":"publisher","DOI":"10.2500\/108854188778607200"},{"key":"e_1_2_4_25_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2260345"},{"key":"e_1_2_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(00)00111-4"},{"key":"e_1_2_4_27_1","first-page":"1223","article-title":"More on interferon\u2010induced cutaneous necrosis","volume":"333","author":"Sheremata WA","year":"1995","journal-title":"N Engl J Med"},{"key":"e_1_2_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(96)80085-7"},{"key":"e_1_2_4_29_1","first-page":"213","article-title":"Cutaneous necrosis caused by injection of \u03b1\u2010interferon in a patient with chronic myelogenous leukemia","volume":"44","author":"Oeda E","year":"1993","journal-title":"Am J Hepatol"},{"key":"e_1_2_4_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1992.01680140150028"},{"key":"e_1_2_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-706X(98)00097-7"},{"key":"e_1_2_4_32_1","doi-asserted-by":"publisher","DOI":"10.1159\/000246316"},{"key":"e_1_2_4_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000372-200208000-00006"},{"key":"e_1_2_4_34_1","first-page":"654","article-title":"A multicenter trial of recombinant human interferon gamma in patients with systemic sclerosis: effects on cutaneous fibrosis and interleukin 2 receptor levels","volume":"23","author":"Polisson RP","year":"1996","journal-title":"J Rheumatol"},{"key":"e_1_2_4_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400110"},{"key":"e_1_2_4_36_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2002.01144.x"}],"container-title":["The Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1346-8138.2004.tb00575.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1346-8138.2004.tb00575.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T19:24:10Z","timestamp":1700162650000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1346-8138.2004.tb00575.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["10.1111\/j.1346-8138.2004.tb00575.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1346-8138.2004.tb00575.x","archive":["Portico"],"relation":{},"ISSN":["0385-2407","1346-8138"],"issn-type":[{"value":"0385-2407","type":"print"},{"value":"1346-8138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}